OUR TEAM
Evan McGill is a three-time Tony Award, Drama Desk Award, and Drama League Award-winning theatrical and music producer whose work spans Broadway, the West End, and Australia. He is a member of the Broadway League and the founder of Evan McGill Productions, where he has played a pivotal role in shaping some of the most celebrated theatrical productions in recent years.
​
On Broadway, his producing credits include Parade (2023), The Sign in Sidney Brustein’s Window (2023), The Outsiders, and Sunset Blvd (2024), and he has held a stake in numerous other commercial productions. Across the pond, McGill is involved in the West End revivals of Andrew Lloyd Webber’s Starlight Express (2024) and Evita (2025), among others. In Australia, he has been involved with Hamilton, MJ, and Beetlejuice. In addition to his work on stage, McGill has produced successful Broadway cast albums including The Music Man: The 2022 Broadway Cast Recording and Funny Girl: New Broadway Cast Recording—both of which debuted at #1 on the Billboard Cast Albums chart.
​
In the world of entertainment finance, McGill serves as a general partner in Tanninger Fund II, an SEC-registered investment vehicle that supports live entertainment ventures on a global scale. His work has earned him three Tony Awards, including Best Revival of a Musical for Parade at the 76th Tony Awards, Best Musical for The Outsiders at the 77th Tony Awards (in collaboration with Tanninger Entertainment), and Best Revival of a Musical for Sunset Blvd. at the 78th Tony Awards. He also received a Drama Desk Award for Parade and a Drama League Award as part of the producing team behind Sunset Blvd.
​
A native of Boston, McGill began acting at the age of six, performing in local community productions of The Who’s Tommy and Alice in Wonderland. He earned a BBA from the University of Miami (FL), an MBA from Columbus State University, and a Master of International Business from Florida International University. Before transitioning into theater, McGill was co-owner of Knit-Rite, a Kansas City–based medical device company specializing in textile solutions for a wide range of patient needs. In 2020, he and his partners sold the company to Thuasne, a global medical firm headquartered in Levallois-Perret, France.
